『How Eli Lilly Is Scaling AI Across Drug Discovery, Manufacturing and Commercial Operations』のカバーアート

How Eli Lilly Is Scaling AI Across Drug Discovery, Manufacturing and Commercial Operations

How Eli Lilly Is Scaling AI Across Drug Discovery, Manufacturing and Commercial Operations

無料で聴く

ポッドキャストの詳細を見る

概要

 At Eli Lilly’s corporate center in Indianapolis, Authentic and Agentic host Jayson Manship speaks with Tim Coleman, Lilly's Chief Technical Officer and Thomas Fuchs, Lilly's Chief AI Officer, about how the global pharmaceutical company made artificial intelligence a strategic priority. The discussion explores how leadership aligned around AI as a long-term transformation, not a short-term experiment. Coleman outlines three pillars that built Lilly’s foundation: experimentation, governance and education. From structured alpha and beta testing to executive education with Purdue University’s Daniels School of Business, the company focused on learning before scaling. Fuchs explains why machine learning is built on repeated failure and how Lilly’s decades of successful and failed experiments create a unique data advantage. The episode highlights applications across the pharmaceutical value chain, including molecular design, digital twins in manufacturing and internally developed AI models. The conversation also addresses executive sponsorship, AI governance, global regulation and the importance of education to remain competitive in the global AI race. For business leaders, the takeaway is clear: lean into your core strengths, focus on real value and ensure leadership engagement at the highest level. Authentic and Agentic is part of the IBJ Media Podcast Network and examines the human side of AI.
まだレビューはありません